Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Non-Current Deferred Tax Liability (2016 - 2021)

Minerva Neurosciences filings provide 3 years of Non-Current Deferred Tax Liability readings, the most recent being $1.8 million for Q3 2021.

  • On a quarterly basis, Non-Current Deferred Tax Liability changed 0.0% to $1.8 million in Q3 2021 year-over-year; TTM through Sep 2021 was $1.8 million, a 0.0% change, with the full-year FY2020 number at $1.8 million, changed 0.0% from a year prior.
  • Non-Current Deferred Tax Liability hit $1.8 million in Q3 2021 for Minerva Neurosciences, roughly flat from $1.8 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q4 2019 to a low of $1.8 million in Q4 2019.
  • Median Non-Current Deferred Tax Liability over the past 3 years was $1.8 million (2019), compared with a mean of $1.8 million.
  • The widest YoY moves for Non-Current Deferred Tax Liability: up 0.0% in 2020, down 0.0% in 2020.
  • Minerva Neurosciences' Non-Current Deferred Tax Liability stood at $1.8 million in 2019, then changed by 0.0% to $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021.
  • The last three reported values for Non-Current Deferred Tax Liability were $1.8 million (Q3 2021), $1.8 million (Q2 2021), and $1.8 million (Q1 2021) per Business Quant data.